Joseph Maakaron, MD, Oncology, Minneapolis, MN, University of Minnesota

JosephMaakaronMD

Oncology Minneapolis, MN

Hematologic Oncology

Assistant Professor of Medicine

Dr. Maakaron is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Maakaron's full profile

Already have an account?

Summary

  • I am a hematologist and medical oncologist specializing in treatment of blood cancers (leukemias and lymphomas) with bone marrow transplantation and cellular therapies.

Education & Training

  • Ohio State University HospitalFellowship, Hematology/Oncology, 2016 - 2019
  • Indiana University School of MedicineResidency, Internal Medicine, 2013 - 2016
  • American University of Beirut Faculty of MedicineClass of 2011, MD, AOA

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2016 - 2021
  • MN State Medical License
    MN State Medical License Active through 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha 2011

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...
    Joseph Maakaron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations